ArticlesDiagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis
Introduction
Historically, asthma control has been pursued by means of symptom and lung function monitoring.1 Although asthma medications are effective in controlling the disease in most patients, a minority deteriorates despite maximum treatment. Non-eosinophilic asthma responds poorly to corticosteroid therapy, the standard treatment for suppressing airway inflammation. About half of patients with asthma seem to be persistently non-eosinophilic.2
Bronchoalveolar lavage and endobronchial biopsy are the reference standards for identifying the extent of eosinophilic airway inflammation, but these tests are invasive and expensive. Another option is induced sputum, which has been clinically useful in guiding asthma treatment.3
A Cochrane review showed that the frequency of asthma exacerbations is significantly lower in patients in whom inhaled corticosteroids are tailored based on sputum eosinophil levels, compared with those in whom management is based on traditional methods of asthma monitoring.3 Recent guidelines recommend guiding treatment in severe asthma by sputum eosinophil counts in addition to clinical criteria in centres experienced in using this technique.1, 4 Sputum eosinophilia might also have prognostic value as a marker for persistent airflow limitation,5 deteriorating asthma over time,6 and responsiveness to future therapies specifically targeting eosinophilic inflammation, such as mepolizumab.7
Unfortunately, sputum induction is time-consuming, needs experienced laboratory personnel, and many patients are unable to produce adequate samples. Several minimally invasive markers of eosinophilic airway inflammation, such as fraction of exhaled nitric oxide (FeNO), blood eosinophils, and serum periostin, could have potential as a surrogate to replace sputum induction, but their accuracy to distinguish between patients with and without airway eosinophilia remains controversial.
We did a systematic review and meta-analysis to obtain summary estimates of the diagnostic accuracy8 of markers for airway eosinophilia in patients with asthma.
Section snippets
Search strategy and selection
A medical information specialist (RS) developed searches in Medline, Embase, and PubMed without date or language restrictions (appendix). We included studies if they had assessed the diagnostic accuracy of one or more blood, serum, nasal lavage, or exhaled breath markers9 (index test) in detecting airway eosinophilia (target condition) in patients with asthma or suspected asthma. Direct airway sampling methods (induced sputum, bronchoalveolar lavage, or endobronchial biopsy) were acceptable
Results
The searches retrieved 2919 unique records, all of them providing titles or abstracts in English language. Among these, we found 21 eligible diagnostic accuracy studies (figure 1). Another 18 studies fulfilled the eligibility criteria for the enrichment sample. Contacting the authors of these studies led to eight additional inclusions. We also included data from two studies from our own department, and one more identified through a conference poster. No additional studies were identified by
Discussion
We systematically reviewed studies on the diagnostic accuracy of minimally invasive markers for detecting airway eosinophilia in asthma. In adults, FeNO, blood eosinophils, and total IgE have been extensively investigated, but their ability to distinguish between patients with and without airway eosinophilia is restricted, with summary estimates of AUC, sensitivity, and specificity never exceeding 0·8. Other markers, such as volatile organic compound analysis, were reported to be more accurate
References (30)
- et al.
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Lancet
(2012) - et al.
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed
J Clin Epidemiol
(2005) - et al.
Changing pattern of sputum cell counts during successive exacerbations of airway disease
Respir Med
(2007) Global strategy for asthma management and prevention 2014
- et al.
A large subgroup of mild-to-moderate asthma is persistently noneosinophilic
Am J Respir Crit Care Med
(2012) - et al.
Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults
Cochrane Database Syst Rev
(2007) - et al.
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Eur Respir J
(2014) - et al.
Factors associated with persistent airflow limitation in severe asthma
Am J Respir Crit Care Med
(2001) - et al.
Eosinophilic airway inflammation and the prognosis of childhood asthma
Clin Exp Allergy
(2007) - et al.
Systematic reviews of diagnostic test accuracy
Ann Intern Med
(2008)